General Information
Revision date
2014-06-30
Product name
Simvastatin
CAS No.
79902-63-9
1.2.1 Relevant identified uses
Additive for cosmetic or pharmaceutic preparations
1.2.2. Uses advised against
No further relevant information available
Emergency telephone
800-423-6967
Icons in SDS
Company Information
company name
Fagron
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H351, H360, H362
Hazard statements
Code
Statements
H351
Suspected of causing cancer
Section 2
CLP CLASSIFICATION
GHS08 health hazard Carc. 2 H351 Suspected of causing cancer. Repr. 1A H360-H362 May damage fertility or the unborn child. May cause harm to breast-fed children.
EU Classification
Directive 67/548/EEC or Directive 1999/45/EC T; Toxic R61: May cause harm to the unborn child. Xn; Harmful R62-40: Possible risk of impaired fertility. Limited evidence of a carcinogenic effect. R64: May cause harm to breastfed babies.
2.2 Label elements
Labelling according to Regulation (EC) No 1272/2008 The substance is classified and labelled according to the CLP regulation.
Hazard pictograms
GHS08
Signal word
Danger
Hazard statements
H351 Suspected of causing cancer. (Contd. of page 1) H360-H362 May damage fertility or the unborn child. May cause harm to breast-fed children.
Precautionary statements
P263 Avoid contact during pregnancy/while nursing. P260 Do not breathe dust/fume/gas/mist/vapours/spray. P281 Use personal protective equipment as required. P308+P313 IF exposed or concerned: Get medical advice/attention. P405 Store locked up. P501 Dispose of contents/container in accordance with local/regional/national/international regulations.
PBT Substances
Not applicable
vPvB Substances
Not applicable
